Clinical trial
Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle…
NCT00110955 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00110955 |
|---|---|
| Title | Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle Chemotherapy |
| Official title | A Randomized, Double-Blind, Placebo-Controlled Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle Chemotherapy |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anemia, Non-Myeloid Malignancies |
| Intervention type | Drug |
| Interventions | Darbepoetin alfa, Placebo |
| Enrollment | 391 |
| Start date | Feb 1, 2004 |
| Primary completion | Mar 1, 2005 |
| Completion | Apr 1, 2005 |
| First posted | May 17, 2005 |
| Last update posted | Jan 15, 2010 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: